Perrigo Co PLC (PRGO)
43.87
+1.34 +3.15%
NYSE
Oct 30, 20:00
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 5.074B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 1.74 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 240.20M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 35.66% |
| Profit Margin (Quarterly) | 4.97% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 2.02% |
| Price and Valuation | |
| Market Cap | 5.987B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 1.185 |
| PE Ratio | 25.21 |
| Price to Book Value | 1.013 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 0.7009 |
| Free Cash Flow (Quarterly) | 264.60M |
| Return on Equity | Upgrade |
View All PRGO News
News
-
WireHeadlineTime (ET)
-
PR Newswire10/29 16:15
-
Yahoo10/29 12:40
-
Yahoo10/28 12:32
-
MT Newswires10/28 12:12
-
Yahoo10/26 18:26
-
SA Breaking News10/22 11:05
-
PR Newswire10/22 10:37
-
Yahoo10/21 12:05
-
Yahoo10/15 09:20
-
PR Newswire10/14 08:15
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 11/25/2020 | Dividends | Amount: 0.225, Declared Date: Oct 22 2020, Pay Date: Dec 15 2020 |
| 11/04/2020 | Earnings | Perrigo Co PLC Third Quarter Earnings Result for 2020 |
| 11/04/2020 16:30 EST | Misc | Perrigo Co PLC Third Quarter Earnings Conference Call for 2020 |
| 08/27/2020 | Dividends | Amount: 0.225, Declared Date: Jul 29 2020, Pay Date: Sep 15 2020 |
| 08/05/2020 09:00 EDT | Misc | Perrigo Co PLC Second Quarter Earnings Conference Call for 2020 |
| 08/05/2020 | Earnings | Perrigo Co PLC Second Quarter Earnings Result for 2020 |
| 05/28/2020 | Dividends | Amount: 0.225, Declared Date: May 05 2020, Pay Date: Jun 16 2020 |
| 05/06/2020 11:30 IST | Misc | Perrigo Co PLC Annual General Meeting for 2019 |
| 04/30/2020 08:30 EDT | Misc | Perrigo Co PLC First Quarter Earnings Conference Call for 2020 |
| 04/30/2020 | Earnings | Perrigo Co PLC First Quarter Earnings Result for 2020 |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: https://www.perrigo.com
- Investor Relations URL: http://perrigo.investorroom.com/
- HQ State/Province: N/A
- Sector: Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Equity Style: Mid Cap/Value
- Next Earnings Release: Nov. 04, 2020
- Last Earnings Release: Aug. 05, 2020
- Next Ex-Dividend Date: Nov. 25, 2020
- Last Ex-Dividend Date: Aug. 27, 2020
- Description: Perrigo is the leading provider of over-the-counter generic drugs with over 100 global locations. The company was formed in 1887 as a packager of home remedies and has grown with the migration of prescriptions switching to OTC and later with strategic acquisitions. The company has a portfolio of more than 3,000 product formulations and 14,000 stock-keeping units. Most of its manufacturing and customer base reside in North America. With the most recent management change, the company announced a narrower focus on consumer wellness in conjunction with the divestiture of animal health, acquisition of Ranir Global Holdings, and plans to sell or spin off the prescription business.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 43.87 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| SSHVX | Sound Shore Institutional | 4.15% |
| XPH | SPDR® S&P Pharmaceuticals ETF | 3.81% |
| FTXH | First Trust Nasdaq Pharmaceuticals ETF | 3.46% |
| TMCTX | Touchstone Mid Cap Z | 2.83% |
| PPH | VanEck Vectors Pharmaceutical ETF | 2.60% |
| IHE | iShares US Pharmaceuticals ETF | 2.39% |
| PILL | Direxion Daily Phrmctcl&MdclBl3XShrsETF | 2.35% |
| GRX | Gabelli Health & Wellness | 1.98% |
| FPHAX | Fidelity® Select Pharmaceuticals Port | 1.50% |
| JMVNX | JHFunds2 Mid Value NAV | 1.39% |
| DTMVX | DFA Tax-Managed US Targeted Value | 0.53% |
| DFTVX | DFA US Targeted Value R1 | 0.43% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- PRGO Tweets Stocktwits
Advertisement
